A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo
Authors:
- Shuei SugamaSSShuei Sugama
- Ronald P. MischakRMRonald P. Mischak
- Mahmoud KiaeiMKMahmoud Kiaei
- Nicolas BizatNBNicolas Bizat
- Emmanuel BrouilletEmmanuel Brouillet
- Tong H. JohTJTong H. Joh
- M. Flint BealMBM. Flint Beal
- 1 November 2004
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 17 (2) , 250-259
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic propertiesApoptosis, 2003
- Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration InducedIn Vivoby 3-Nitropropionate: Implications for Huntington's DiseaseJournal of Neuroscience, 2003
- Malonate and 3‐Nitropropionic Acid Neurotoxicity Are Reduced in Transgenic Mice Expressing a Caspase‐1 Dominant‐Negative MutantJournal of Neurochemistry, 2000
- Replicating Huntington's disease phenotype in experimental animalsProgress in Neurobiology, 1999
- Caspase and calpain substrates: Roles in synaptic plasticity and cell deathJournal of Neuroscience Research, 1999
- Oxidative stress is attenuated in mice overexpressing BCL-2Neuroscience Letters, 1999
- Metabolic Compromise with Systemic 3-Nitropropionic Acid Produces Striatal Apoptosis in Sprague–Dawley Rats but Not in BALB/c ByJ MiceExperimental Neurology, 1998
- 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neuronsNeuroReport, 1995
- Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acidThe Journal of Neuroscience, 1993
- Kynurenine Pathway Measurements in Huntington's Disease Striatum: Evidence for Reduced Formation of Kynurenic AcidJournal of Neurochemistry, 1990